Our Mission

Cytovance Biologics' mission is to become a value-added partner to our clients by providing an integral pathway in converting today's novel protein discoveries into future life saving therapies and diagnostics. 

Cytovance Biologics is your partner in biopharmaceutical contract manufacturing of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation.

Latest News

Cytovance Biologics, Inc. Secures $20 Million Credit Facility

Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, announces that it has secured a $20 Million Credit Facility from Monroe Capital.


Cytovance Biologics Announces the Launch of Keystone Expression System™

Cytovance Biologics launches innovative Keystone Expression System™, an E. coli expression platform using a toolbox approach to gene design, host construction, and screening evaluation.


Cytovance Biologics selected forGMP manufacture of AM0010 for ARMO BioSciences

Cytovance Biologics announces successful GMP manufacture of ARMO BioSciences’ lead product, AM0010, a PEGylated form of recombinant human interleukin-10 (IL-10).

 

>> READ MORE CYTOVANCE NEWS

Careers

cGMP Manufacturing Careers at Cytovance Biologics
 

We are searching for talented life science professionals to join the Cytovance team.
 

>> SEE ALL CYTOVANCE JOB OPENINGS

 

 

Conferences

Contracting and Outsourcing Conference in New Brunswick, NJ
September 18-19, 2014


CPhI Worldwide, Paris, France
October 7-9, 2014


BioProcess International, Boston, MA
October 20-23, 2014


>> READ FULL EVENT CALENDAR